ZENURA Trademark

Trademark Overview

On Thursday, March 29, 2018, a trademark application was filed for ZENURA with the United States Patent and Trademark Office. The USPTO has given the ZENURA trademark a serial number of 87855503. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 1, 2022. This trademark is owned by Janssen Sciences Ireland UC. The ZENURA trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, respiratory diseases, digital ulcers, cerebrovascular diseases, and viral diseases excluding antivirals for the treatment of liver disease and HIV infection; vaccines; anxiolytics; anti-allergics; anti-infectives
zenura

General Information

Serial Number87855503
Word MarkZENURA
Filing DateThursday, March 29, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 1, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2018

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, respiratory diseases, digital ulcers, cerebrovascular diseases, and viral diseases excluding antivirals for the treatment of liver disease and HIV infection; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 5, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
Party Type21 - New Owner After Publication
Legal Entity Type79 - NOT AVAILABLE
AddressRINGASKIDDY, CO CORK
IE
Party NameJanssen Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCounty Cork
IE
Party NameJanssen Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCounty Cork
IE

Trademark Events

Event DateEvent Description
Monday, August 1, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 1, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 10, 2021SOU EXTENSION 5 GRANTED
Wednesday, December 1, 2021SOU EXTENSION 5 FILED
Friday, December 10, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 1, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, November 10, 2021ASSIGNED TO EXAMINER
Saturday, June 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 10, 2021SOU EXTENSION 4 GRANTED
Thursday, June 10, 2021SOU EXTENSION 4 FILED
Thursday, June 10, 2021SOU TEAS EXTENSION RECEIVED
Saturday, December 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 3, 2020SOU EXTENSION 3 GRANTED
Thursday, December 3, 2020SOU EXTENSION 3 FILED
Thursday, December 3, 2020SOU TEAS EXTENSION RECEIVED
Friday, June 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 17, 2020SOU EXTENSION 2 GRANTED
Wednesday, June 17, 2020SOU EXTENSION 2 FILED
Wednesday, June 17, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, March 18, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, November 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2019SOU EXTENSION 1 GRANTED
Monday, November 18, 2019SOU EXTENSION 1 FILED
Monday, November 18, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 10, 2019TTAB RELEASE CASE TO TRADEMARKS
Friday, May 10, 2019OPPOSITION TERMINATED NO. 999999
Friday, May 10, 2019OPPOSITION DISMISSED NO. 999999
Monday, November 26, 2018OPPOSITION INSTITUTED NO. 999999
Friday, August 24, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 31, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 20, 2018ASSIGNED TO LIE
Tuesday, June 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 12, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, June 12, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 12, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, June 12, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, June 11, 2018ASSIGNED TO EXAMINER
Thursday, April 5, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 2, 2018NEW APPLICATION ENTERED

Related Keywords

zenura diseases treatment anti system cerebrovascular viral ulcers respiratory metabolic oncologic